Un characterized protein C1orf105: A potential drug target and biomarker

Target Name: C1orf105

NCBI ID: G92346

C1orf105

Un characterized protein C1orf105: A potential drug target and biomarker

Abstract:
C1orf105 is a unique protein that has been identified as a potential drug target and biomarker. Its structure, function, and potential clinical applications make it an attractive candidate for further research. This article aims to provide an overview of C1orf105, including its structure, function, and potential clinical applications.

Introduction:
Proteins are the building blocks of life and play a crucial role in various biological processes. They are involved in almost every cellular function, including growth, development, and reproduction. One of the proteins that has garnered significant attention in recent years is C1orf105. This protein has been identified as a potential drug target and biomarker, making it an attractive candidate for further research.

Structure and Function:
C1orf105 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. Its structure is similar to that of other transcription factors, such as NF-kappa-B and p53. It consists of a amino-acid sequence that is similar to that of the T-cell receptor (TCR), which is a protein that plays a critical role in cell signaling.

One of the unique features of C1orf105 is its ability to interact with various transcription factors, including NF-kappa-B, p53, and TCR. This interaction between C1orf105 and these transcription factors makes it a potential drug target. C1orf105 has been shown to play a role in regulating cell signaling pathways, including the regulation of cell growth, apoptosis, and inflammation.

C1orf105 has also been shown to be involved in the regulation of gene expression. It has been shown to interact with various gene transcription factors, including NF-kappa-B, p53, and HIF1浼?. This interaction between C1orf105 and these transcription factors makes it a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

Potential Clinical Applications:
C1orf105's potential as a drug target and biomarker makes it an attractive candidate for further research. Its interaction with transcription factors and ability to regulate gene expression make it a potential target for small molecules or antibodies that can modulate its activity. This could lead to the development of new treatments for various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

For example, C1orf105 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. Many diseases, including cancer, are characterized by the regulation of apoptosis, which can lead to the development of resistance to treatment. By targeting C1orf105, researchers could potentially develop new treatments for cancer.

C1orf105 has also been shown to be involved in the regulation of inflammation. Many diseases, including cardiovascular disease and neurodegenerative diseases, are characterized by the production of inflammation-promoting molecules. By targeting C1orf105, researchers could potentially develop new treatments for these diseases.

Conclusion:
C1orf105 is a unique protein that has been identified as a potential drug target and biomarker. Its structure and function, as well as its ability to interact with various transcription factors and regulate gene expression, make it an attractive candidate for further research. Further studies are needed to determine its potential clinical applications and to develop new treatments for various diseases.

Protein Name: Chromosome 1 Open Reading Frame 105

The "C1orf105 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1orf105 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets